Table_1_Deep Learning on Enhanced CT Images Can Predict the Muscular Invasiveness of Bladder Cancer.docx (13.96 kB)
Download file

Table_1_Deep Learning on Enhanced CT Images Can Predict the Muscular Invasiveness of Bladder Cancer.docx

Download (13.96 kB)
dataset
posted on 11.06.2021, 05:18 by Gumuyang Zhang, Zhe Wu, Lili Xu, Xiaoxiao Zhang, Daming Zhang, Li Mao, Xiuli Li, Yu Xiao, Jun Guo, Zhigang Ji, Hao Sun, Zhengyu Jin
Background

Clinical treatment decision making of bladder cancer (BCa) relies on the absence or presence of muscle invasion and tumor staging. Deep learning (DL) is a novel technique in image analysis, but its potential for evaluating the muscular invasiveness of bladder cancer remains unclear. The purpose of this study was to develop and validate a DL model based on computed tomography (CT) images for prediction of muscle-invasive status of BCa.

Methods

A total of 441 BCa patients were retrospectively enrolled from two centers and were divided into development (n=183), tuning (n=110), internal validation (n=73) and external validation (n=75) cohorts. The model was built based on nephrographic phase images of preoperative CT urography. Receiver operating characteristic (ROC) curves were performed and the area under the ROC curve (AUC) for discrimination between muscle-invasive BCa and non-muscle-invasive BCa was calculated. The performance of the model was evaluated and compared with that of the subjective assessment by two radiologists.

Results

The DL model exhibited relatively good performance in all cohorts [AUC: 0.861 in the internal validation cohort, 0.791 in the external validation cohort] and outperformed the two radiologists. The model yielded a sensitivity of 0.733, a specificity of 0.810 in the internal validation cohort and a sensitivity of 0.710 and a specificity of 0.773 in the external validation cohort.

Conclusion

The proposed DL model based on CT images exhibited relatively good prediction ability of muscle-invasive status of BCa preoperatively, which may improve individual treatment of BCa.

History